Tower Research Capital (TRC)’s Burning Rock Biotech BNR Stock Holding History

Tower Research Capital (TRC)’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Buy	1,242 +1,214	+4,336%	+$17.2K	﹤0.01%	3985
2026 Q1	$452	Buy	+28	New	+$733	﹤0.01%	4869
2025 Q1	–	Sell	-192	Closed	-$1.3K	–	5222
2024 Q4	$1.3K	Buy	192 +14	+8%	+$64	﹤0.01%	5053
2024 Q3	$582	Sell	178 -83	-32%	-$458	﹤0.01%	5306
2024 Q2	$1.64K	Buy	+261	New	+$1.99K	﹤0.01%	5117
2023 Q4	–	Sell	-17	Closed	-$169	–	5929
2023 Q3	$169	Sell	17 -68	-80%	-$1.06K	﹤0.01%	5676
2023 Q2	$1.82K	Buy	+85	New	+$2.25K	﹤0.01%	5308
2023 Q1	–	Sell	-1,237	Closed	-$28K	–	5822
2022 Q4	$28K	Buy	1,237 +698	+129%	+$15.9K	﹤0.01%	2801
2022 Q3	$13K	Sell	539 -34	-6%	-$1.1K	﹤0.01%	4257
2022 Q2	$16K	Buy	573 +328	+134%	+$14.6K	﹤0.01%	3999
2022 Q1	$23K	Buy	245 +222	+965%	+$19.3K	﹤0.01%	3387
2021 Q4	$2K	Buy	+23	New	+$3.15K	﹤0.01%	5599
2021 Q3	–	Sell	-7	Closed	-$2K	–	5772
2021 Q2	$2K	Buy	+7	New	+$2.07K	﹤0.01%	5019

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s BNR Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Burning Rock Biotech (BNR) stake by 4,336% in Q2 2026, buying an estimated $17.2K and bringing the position to 1,242 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3985.

Tower Research Capital (TRC) first reported a position in BNR in Q2 2021 and has held it in 13 quarters since. The position peaked at $28K in Q4 2022. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

Tower Research Capital (TRC) held 1,242 shares of Burning Rock Biotech worth $10.4K as of Q2 2026.
Tower Research Capital (TRC) bought 1,214 Burning Rock Biotech shares in Q2 2026, an estimated $17.2K.
Burning Rock Biotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3985 holding.
Tower Research Capital (TRC) first reported a position in Burning Rock Biotech in Q2 2021 and has held it in 13 quarters since.
Tower Research Capital (TRC)'s Burning Rock Biotech position peaked at $28K in Q4 2022.
17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.